BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $8.09 million. The enterprise value is $82.61 million.

Market Cap	8.09M
Enterprise Value	82.61M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BTAI has 5.47 million shares outstanding. The number of shares has increased by 75.70% in one year.

Current Share Class	5.47M
Shares Outstanding	5.47M
Shares Change (YoY)	+75.70%
Shares Change (QoQ)	+59.07%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	4.46%
Float	4.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.61
Forward PS	3.24
PB Ratio	-0.09
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	44.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.48

Current Ratio	1.48
Quick Ratio	1.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-52.47%
Return on Invested Capital (ROIC)	-139.93%
Return on Capital Employed (ROCE)	-389.71%
Revenue Per Employee	$50,054
Profits Per Employee	-$1.08M
Employee Count	37
Asset Turnover	0.03
Inventory Turnover	1.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.57% in the last 52 weeks. The beta is 0.08, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-95.57%
50-Day Moving Average	2.06
200-Day Moving Average	6.75
Relative Strength Index (RSI)	36.07
Average Volume (20 Days)	77,857

Short Selling Information

The latest short interest is 87,945, so 1.61% of the outstanding shares have been sold short.

Short Interest	87,945
Short Previous Month	74,295
Short % of Shares Out	1.61%
Short % of Float	1.89%
Short Ratio (days to cover)	0.19

Income Statement

In the last 12 months, BTAI had revenue of $1.85 million and -$40.06 million in losses. Loss per share was -$12.28.

Revenue	1.85M
Gross Profit	-225,000
Operating Income	-50.74M
Pretax Income	n/a
Net Income	-40.06M
EBITDA	-50.43M
EBIT	-50.74M
Loss Per Share	-$12.28

Full Income Statement

Balance Sheet

The company has $31.01 million in cash and $105.53 million in debt, giving a net cash position of -$74.51 million or -$13.63 per share.

Cash & Cash Equivalents	31.01M
Total Debt	105.53M
Net Cash	-74.51M
Net Cash Per Share	-$13.63
Equity (Book Value)	-90.17M
Book Value Per Share	-16.49
Working Capital	12.23M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-66.36M
Capital Expenditures	n/a
Free Cash Flow	-66.36M
FCF Per Share	-$12.14

Full Cash Flow Statement

Margins

Gross Margin	-12.15%
Operating Margin	-2,739.74%
Pretax Margin	-2,163.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.70%
Shareholder Yield	-75.70%
Earnings Yield	-495.04%
FCF Yield	-820.05%

Analyst Forecast

The average price target for BTAI is $42.60, which is 2,778.38% higher than the current price. The consensus rating is "Buy".

Price Target	$42.60
Price Target Difference	2,778.38%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	137.01%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 0.0625:1.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	0.0625:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2